Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib Ansgar BrĂĽningPetra BurgerAlexander Burges PRECLINICAL STUDIES 26 June 2009 Pages: 535 - 542
Effect of a Vitamin D3 derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model Thilo S. LangeAshley R. StuckeyLaurent Brard PRECLINICAL STUDIES 07 July 2009 Pages: 543 - 553
An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines Efstathia GiannopoulouKonstantinos DimitropoulosHaralabos P. Kalofonos PRECLINICAL STUDIES 15 July 2009 Pages: 554 - 560
Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies Gadi Gazit BornsteinChristophe QuévaDavid Blakey PRECLINICAL STUDIES 21 July 2009 Pages: 561 - 574
The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells Sharon A. MasonSarah-Jane CozziGlen M. Boyle PRECLINICAL STUDIES 28 July 2009 Pages: 575 - 586
Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes Tushar S. Basu BaulAnup PaulDick de Vos PRECLINICAL STUDIES 30 July 2009 Pages: 587 - 599
Synthesis and biological properties of oxazolinodaunorubicin—a new derivative of daunorubicin with a modified daunosamine moiety Malgorzata LukawskaJoanna WietrzykIrena Oszczapowicz PRECLINICAL STUDIES 28 August 2009 Pages: 600 - 608
In vitro cytotoxic evaluation of novel dichlorodiorgano[N-(2-pyridylmethylene)arylamine]tin(IV) derivatives in human tumor cell lines Tushar S. Basu BaulDick de Vos PRECLINICAL STUDIES 27 August 2009 Pages: 609 - 614
Studies on the neuroprotective role of Piper longum in C6 glioma induced rats Umadevi SubramanianSharmila PoongavanamA. J. Vanisree PRECLINICAL STUDIES 03 September 2009 Pages: 615 - 623
Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis Saravana Kumar JaganathanMahitosh Mandal PRECLINICAL STUDIES 25 August 2009 Pages: 624 - 633
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer Stacy MoulderNavneet DhillonRazelle Kurzrock PHASE I STUDIES 06 June 2009 Pages: 634 - 640
Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors Radharani GollamudiMohammad H. GhalibSanjay Goel PHASE I STUDIES 02 July 2009 Pages: 641 - 649
A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer Sang Joon ShinHei-Cheul JeungHyun Cheol Chung PHASE I STUDIES 08 July 2009 Pages: 650 - 658
Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer In Hae ParkJungsil RoByung Ho Nam PHASE II STUDIES 04 July 2009 Pages: 659 - 669
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma Jennifer WuCharles HendersonAndrew X. Zhu PHASE II STUDIES 30 June 2009 Pages: 670 - 676
Phase II study of sunitinib malate in head and neck squamous cell carcinoma Nicholas W. ChoongMark KozloffEzra E. W. Cohen PHASE II STUDIES 04 August 2009 Pages: 677 - 683
Oral metronomic cyclophosphamide in elderly with metastatic melanoma Estelle BorneEve DesmedtLaurent Mortier PRECLINICAL STUDIES 12 August 2009 Pages: 684 - 689
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma Judith MichelsNathalie LassauBernard Escudier SHORT REPORT 24 June 2009 Pages: 690 - 693
Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogs Joseph A. BauerGerald FryePeter Brofman SHORT REPORT 27 June 2009 Pages: 694 - 702
Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response Gurpreet KaurMohammad AtharM. Sarwar Alam SHORT REPORT 10 July 2009 Pages: 703 - 713